TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004% TRAVOPROST
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004% TRAVOPROST, covering 2019-12-20 to 2019-12-20. Get the full timeline:
Most recent: FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004% TRAVOPROST — Original Application (Alembic Pharmaceuticals Inc.)